Latest / The BioHub - by Avetix
Episode 176 - Asa Abeliovich - CEO & Founder at Leal Therapeutics
In this episode, Ben sits down with Asa Abeliovich, MD, PhD, Founder and CEO of Leal Therapeutics, to talk about Leal’s mission to develop precision medicines for some of the most complex and underserved neurodegenerative diseases.
The conversation explores how Leal is using human genetics, disease biology, and translational neuroscience to build a pipeline focused on conditions such as Parkinson’s disease, Alzheimer’s disease, and ALS. Asa discusses the rationale behind Leal’s approach, the importance of selecting the right biological targets, and the challenges of turning genetic insight…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.